PRCT vs AORT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 28, 2026

PRCT

39.0
AI Score
VS
AORT Wins

AORT

42.9
AI Score

Investment Advisor Scores

PRCT

39score
Recommendation
EXTENDED

AORT

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PRCT AORT Winner
Forward P/E 0 34.6021 Tie
PEG Ratio 0 181.5 Tie
Revenue Growth 19.3% 11.3% PRCT
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 39.0/100 42.9/100 AORT
Profit Margin -32.5% -0.7% AORT
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

PRCT 1M: +10.9% · 3M: +12.2% AORT 1M: +0.3% · 3M: -17.2%

Current Technical Phase

PRCT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 58.5 · Price: $20.20

AORT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.7 · Price: $22.92

Fundamentals Snapshot

Metric PRCT AORT
Market Cap — —
Forward P/E -17.2 30.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.2% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin -0.3% 0.1%
EPS -1.94 -0.07
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AORT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.